Tissue Expanders Market Size, Share & Trends Analysis Report By Application, By Shape (Anatomical, Round, Rectangular), By End-use (Hospitals, Cosmetology Clinics, Ambulatory Surgical Centers), By Region, And Segment Forecasts, 2023 - 2030

Tissue Expanders Market Size & Trends

The global tissue expanders market size was valued at USD 649.2 million in 2022 and is anticipated to expand at a compound annual growth rate (CAGR) of 6.4% from 2023 to 2030. The market expansion is attributed to an increase in the number of reconstruction surgeries performed in the healthcare sector in recent years. According to the American Society of Plastic Surgeons, over 1 million reconstructive procedures were performed in the U.S. in 2022. Specific anatomical locations which require reconstruction procedures using tissue expanders include the face, neck, arms, legs, and breasts. The increase in breast reconstruction procedures such as mastectomy and lumpectomy is one of the key factors driving market growth for tissue expanders.

In recent years, obesity, the use of alcohol, and an unhealthy lifestyle have led to the increasing prevalence of breast cancer, which has become a prominent ailment where tissue expanders are used as implants. According to the Breast Cancer Research Foundation (BCRF), the disease is considered to be the most common type among American women after skin cancer. BCRF also estimated that in 2020, about 2.3 million women were diagnosed with breast cancer worldwide, with 685,000 deaths. It has also been estimated that globally, a woman is diagnosed with breast cancer every 14 seconds.

In addition to mastectomy and lumpectomy procedures, road accidents are one of the major drivers of this market. WHO estimates that every year, around 10 million people are injured due to accidents that lead to scars and anatomical disablements involving the face, neck, legs, etc. The other key drivers include increasing awareness about physical appearance and beauty among people, leading to plastic surgeries requiring tissue expansions.

However, restraints such as the rejection of implanted tissues, the pain and discomfort caused, the operating time, and high equipment costs hamper market growth for tissue expanders. The COVID-19 pandemic had a negative impact on the market. Reconstructive procedures involving tissue implants and expansions were disturbed during this adverse healthcare environment. Healthcare units were focused on expanding their COVID wards to save lives. As reconstructive procedures are non-emergency, the tissue expanders industry witnessed a slowdown due to healthcare institutions' prioritization of emergency cases.

Shape Insights

Based on the shape of the products used in the procedures, the industry is segmented into anatomical, rectangular, crescent, round, and other shapes. The anatomical segment dominated the market with the largest revenue share in 2022. Women increasingly opt for anatomical-shaped expanders as they provide a greater degree of protection, are soft and round, look natural, and provide accurate breasts.

On the other hand, the round-shaped tissue expanders segment is expected to advance at the fastest CAGR from 2023 to 2030. Dermaspan, manufactured by Sientra, Inc., is a round/anatomically shaped tissue expander that helps achieve soft breasts with the desired shape. The rectangular-shaped products segment is also expected to grow at a lucrative CAGR over the forecast period. These products are used in neck, face, arms, and leg reconstruction procedures. Their demand is also anticipated to grow significantly over the upcoming years.

These expanders are of two types - silicon-based and saline-filled. Crescent-based tissue expanders are another type used for breast implants. As breast cancer is one of the most prominent contributors to the market’s expansion, crescent implants have become highly important. These products are also used in procedures involving other body parts apart from breasts. ACX, manufactured by Sientra, Inc., is used for two-stage reconstructions, and a rectangular tissue expander manufactured by Groupe Sebbin is used for tissue augmentation surgeries.

End-use Insights

On the basis of end-use, the market is segmented into hospitals, cosmetology clinics, and ambulatory surgical centers. The hospital segment dominated the market with the largest revenue share in 2022, owing to the continued increase in the number of breast cancer patients being treated at various hospitals, which provide their patients with proper facilities for implant procedures.

On the other hand, the cosmetology clinics segment is expected to witness significant growth during the forecast period. This growth is attributed to the increasing demand for these clinics from people that are more conscious about their appearance & aesthetics and lifestyle changes.

Application Insights

The breast reconstruction segment dominated the market with the largest revenue share of 44.9% in 2022 and is also expected to expand at the fastest CAGR of 6.8% over the forecast period. An increase in the number of breast reconstructive surgeries performed after mastectomy is fueling the growth of this segment. On the basis of application, the tissue expanders market is segmented into breast reconstruction, forehead skin and scalp reconstruction, face and neck reconstruction, and others.

The forehead skin and scalp reconstructions segment, on the other hand, is expected to progress at a lucrative CAGR during the forecast period. The segment growth is attributed to the need for surgical procedures for scalp reduction due to a rise in trauma & burn cases and an increase in accidents that lead to scalp and forehead damage.

Regional Insights

North America dominated the market with the largest revenue share of 43.4% in 2022. The availability of advanced healthcare facilities and extensive infrastructure have been fueling the industry’s growth in the region. According to the Global Survey 2021 by the International Society of Aesthetic Plastic Surgery (ISAPS), the U.S. performed 24.1% of the total number of global procedures. Additionally, an increase in the prevalence of breast cancer cases in Canada has contributed to the significant revenue share of this region.

The Asia Pacific region, on the other hand, is expected to expand at the fastest CAGR of 8.0% over the forecast period from 2023 to 2030. The promising growth has been attributed to the increasing incidences of road mishaps in India. In addition, China constitutes the world's largest cosmetic industry, which is further expected to fuel market growth in the region.

Key Companies & Market Share Insights

Key strategies implemented by major industry companies include the development of new products & strategic partnerships, as well as regional expansions. In 2022, GC Aesthetics, an Ireland-based reconstructive solutions provider, announced the approval of ‘LUNA xt’, a micro-textured implant. It is the first breast implant worldwide to be approved under the European MDR (Medical Device Regulation).

Similarly, in another notable development in January 2022, Sientra announced the acquisition of AuraGen Aesthetics to grow its plastic surgery business across the U.S. This initiative has enabled Sientra to expand its business into the aesthetic procedures of face and hands.

Tissue Expanders Market Report Scope

Global Tissue Expanders Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2018 to 2030. For the purpose of this study, Grand View Research, Inc. has segmented the global tissue expanders market report on the basis of application, shape, end-use, and region:

• Application Outlook (Revenue, USD Million, 2018 - 2030)

  • Breast Reconstruction

    • Two-stage Breast Reconstruction

    • Single-stage Breast Reconstruction

  • Forehead Skin and Scalp Reconstruction

  • Face and Neck Reconstruction

  • Others

• Shape Outlook (Revenue, USD Million, 2018 - 2030)

  • Anatomical

  • Round

  • Rectangular

  • Crescent

  • Others

• End-use Outlook (Revenue, USD Million, 2018 - 2030)

  • Hospitals

  • Cosmetology Clinics

  • Ambulatory Surgical Centers

• Regional Outlook (Revenue, USD Million, 2018 - 2030)

  • North America

    • U.S.

    • Canada

  • Europe

    • U.K.

    • Germany

    • France

    • Italy

    • Spain

    • Denmark

    • Sweden

    • Norway

  • Asia Pacific

    • Japan

    • China

    • India

    • Australia

    • Thailand

    • South Korea

  • Latin America

    • Brazil

    • Mexico

    • Argentina

  • Middle East & Africa

    • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait